RCT of Misoprostol for Postpartum Hemorrhage in India
Completed
Bill and Melinda Gates Foundation
N/A
2002-09-01
Death rates for pregnant women in rural India are approximately forty-five times higher than
in the United States. Bleeding after the birth of a child and underlying anemia are the
primary causes of mothers' deaths and sickness in rural India. This study assesses the
effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the
incidence of maternal bleeding following births assisted by midwives in selected sites in
Belgaum District, Karnataka, India.
RCT of Misoprostol for Postpartum Hemorrhage in India
Completed
Fogarty International Center of the National Institute of Health
N/A
2002-09-01
Death rates for pregnant women in rural India are approximately forty-five times higher than
in the United States. Bleeding after the birth of a child and underlying anemia are the
primary causes of mothers' deaths and sickness in rural India. This study assesses the
effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the
incidence of maternal bleeding following births assisted by midwives in selected sites in
Belgaum District, Karnataka, India.
RCT of Misoprostol for Postpartum Hemorrhage in India
Completed
Global Network for Women's and Children's Health Research
N/A
2002-09-01
Death rates for pregnant women in rural India are approximately forty-five times higher than
in the United States. Bleeding after the birth of a child and underlying anemia are the
primary causes of mothers' deaths and sickness in rural India. This study assesses the
effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the
incidence of maternal bleeding following births assisted by midwives in selected sites in
Belgaum District, Karnataka, India.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
